Home  |  log in boards stocks commodities forex the lounge hot! viagra daily dose price Breakout boards ihub my stocks activity ticker buzz cloud top boards most read most posted most followed members recent news active boards site stats new boards hot on stockwiki auditorium data tools charts trader alerts trades portfolio top lists news alerts commodities more tools  my image gallery advanced search videos all news stock screener news filter live charts live news live desktop forex prices commodities etf center online brokers educational channel streamer level 2 home > boards > stock clubs > market trends and strategies > $heff's $tation of $tocks & $olid dd astx:astex pharmaceuticals earns $5 million for first commercial public reply  |  private reply  |  keep  |  last read post new msg next 10  |  previous  |  next investor100   tuesday, october 09, 2012 9:06:25 am re: none post # of 60390  astx:astex pharmaceuticals earns $5 million for first commercial sale of dacogen(r) in the european union pps:$2. viagra samples 87 dublin, calif. , oct. 9, 2012 (globe newswire) -- astex pharmaceuticals, inc. viagra safe use after expiration date (astx), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, announced that a $5 million dollar milestone was earned from eisai inc. , for the first commercial sale of dacogen(r) in the european union. generic viagra without prescription Dr. viagra canada James s. J. Manuso, astex chairman and chief executive officer, commented, "dacogen will continue to help patients around the world in the years ahead, and royalties on its sales will contribute to the funding of our prioritized development programs. " janssen-cilag international nv and its affiliates hold marketing and development rights for dacogen in all markets except the united states, canada and mexico, where rights are maintained by their strategic partner, eisai inc. viagra for sale online cheap And its affiliates. viagra without a doctor prescription These marketing rights flow from a worldwide license from astex pharmaceuticals to eisai inc. Astex receives royalties from eisai inc. On the global sales of dacogen for any indication starting at 20% and escalating to a maximum of 30%. In accordance with astex's license agreement with eisai, astex may receive up to $12. 5 million in future payments if additional milestones are achieved for dacogen globally. where can i buy viagra online uk About dacogen (decitabine) dacogen is a dna hypomethylating agent currently approved for the treatment of myelodysplastic syndromes (mds) in more than 35 countries worldwide including key markets such as the united states, brazil, china, india, korea, russia and turkey. viagra generic On september 28, 2012 janssen-cilag international nv announced that the european commission (ec) had granted marketing authorization for dacogen (decitabine) for the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute mye.